{"id":24608,"date":"2026-04-01T11:00:00","date_gmt":"2026-04-01T09:00:00","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=24608"},"modified":"2026-04-01T14:47:33","modified_gmt":"2026-04-01T12:47:33","slug":"adragos-pharma-acquires-prefilled-syringes-facility-paris","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/adragos-pharma-acquires-prefilled-syringes-facility-paris\/","title":{"rendered":"Adragos\u00a0Pharma\u00a0finalizes\u00a0the\u00a0acquisition of Commercial-Scale\u00a0Sterile Fill-Finish Manufacturing Site at Maisons-Alfort, France, from Sanofi"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Munich, April 1, 2026<\/strong> \u2013 Adragos\u00a0Pharma, a global contract development and manufacturing organization (CDMO), today announced that it\u00a0completed the acquisition of a\u00a0commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The\u00a0Maisons-Alfort\u00a0site is one of Europe\u2019s largest manufacturing facilities for sterile injectables,\u00a0with industrial-scale capacity for pre-filled syringes\u00a0(PFS), as well as\u00a0liquid and\u00a0lyophilized vials.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The facility,&nbsp;located&nbsp;in the south-eastern suburbs of Paris is regularly audited by&nbsp;international health authorities, including ANSM (France), NMPA (China), MFDS (South Korea), and ANVISA (Brazil),&nbsp;and supports the global supply of critical injectable medicines.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Maisons-Alfort site employees are joining Adragos Pharma, bringing with them expertise in Sterile Manufacturing, ensuring full operational continuity while preserving the technical excellence built over the years. This complete talent integration represents a major strategic asset for the site&#8217;s future.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This&nbsp;site&nbsp;significantly expands&nbsp;Adragos\u2019 sterile injectables network, adding high-volume pre-filled syringe manufacturing capabilities to its existing vial and ampoule filling operations in Jura, Switzerland, and&nbsp;Livron, France. The combined platform establishes&nbsp;Adragos&nbsp;as one of the leading sterile injectables&nbsp;CDMOs in Europe.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Andreas Raabe, Founder and CEO of Adragos Pharma, commented:&nbsp;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><em>\u201cMaisons-Alfort is a landmark acquisition for Adragos and a defining step in our growth journey. We are adding one of Europe\u2019s leading sterile manufacturing sites to our network. Our ambition is clear: to invest, scale, and further develop the site into a top-tier fill-finish platform. This transaction is fully aligned with our strategy to secure and expand highly differentiated pharmaceutical manufacturing capacity in Europe.\u201d<\/em>&nbsp;<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">Moritz Hafner, Partner at FSN Capital (investment advisor to FSN Capital VI), added:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><em>&#8220;This acquisition is a significant step in our strategy to build&nbsp;Adragos&nbsp;into a leading player in the European pharmaceutical CDMO market. The Maisons-Alfort site is a strong strategic fit \u2013 it enhances&nbsp;Adragos\u2019 sterile injectables capabilities and adds a highly experienced team that will further strengthen the&nbsp;Adragos&nbsp;platform. We are&nbsp;very proud&nbsp;of the trust that Sanofi places in&nbsp;Adragos&nbsp;to continue producing life-saving medicine. We look forward to the journey ahead with the&nbsp;Adragos&nbsp;management team as we continue to grow and serve the increasing customer demand for high-quality pharmaceutical products.&#8221;<\/em><\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">Philippe Charreau, Head of Manufacturing &amp; Supply Sanofi France:&nbsp;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><em>&#8220;For decades, Maisons-Alfort has been a cornerstone of sterile manufacturing for Sanofi&#8217;s most trusted products, built on deep expertise, advanced capabilities, and the unwavering commitment of its employees. We are confident that Adragos will carry forward the site&#8217;s tradition of operational excellence, leveraging the exceptional talent and experience of these teams to continue serving patients and write a successful new chapter for this site.&#8221;<\/em>&nbsp;<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">The exact terms of the transaction will not be disclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About Adragos<\/strong> Pharma&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Adragos Pharma is a global CDMO headquartered in Munich, Germany, focused on the development and manufacturing of pharmaceutical products. The company is building a differentiated international network across Europe and Japan, with a strong focus on sterile injectables and complex dosage forms. Adragos operates manufacturing sites in France, Germany, Switzerland, and Japan, as well as a development site in Greece, and is backed by FSN Capital and the Prange Family Office.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Media&nbsp;inquiries:&nbsp;<a href=\"mailto:publicrelations@adragos-pharma.com\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>publicrelations@adragos-pharma.com<\/strong><\/a>&nbsp;<br><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich, April 1, 2026 \u2013 Adragos\u00a0Pharma, a global contract development and manufacturing organization (CDMO), today announced that it\u00a0completed the acquisition of a\u00a0commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The\u00a0Maisons-Alfort\u00a0site is one of Europe\u2019s largest manufacturing facilities for sterile [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":24382,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[12],"tags":[],"topics":[],"locations":[370],"experts":[],"class_list":["post-24608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","locations-maisons-alfort"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/24608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=24608"}],"version-history":[{"count":6,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/24608\/revisions"}],"predecessor-version":[{"id":24706,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/24608\/revisions\/24706"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/24382"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=24608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=24608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=24608"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=24608"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=24608"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=24608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}